chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A nurse reported that 60 to 75 % of the residents and staff of long term care facility received vax on Oct 10, 1999. With in 1 to 2 days they developed nausea, vomiting and diarrhea which lasted approximately 72 hours or longer. The reporter also stated that some patients rec pnuemococcal vax, the reporter was unable to specify the number of residents and staff who experienced this event.
Patient received vaccine on 1/8/21 at 10:30am. On the night of 1/9/21 patient started to feel strong urge to scratch due to itchiness on the site of the injection. The injection site raised a bit, feeling swollen. The next day one hour to 2 hours later after waking up patient started to feel itchy sensation everywhere. Patient noticed measles-like red pumps all over the upper torso of the body. Approximately on 1/14/21 patient's symptoms subsided and went away completely.
After receiving the second shot I immediately became tired and nauseous with a pounding headache but it went away after an hour. I received the shot at 2:30 pm on the 29th. At about 1:10 am I started uncontrollably shaking, could not move my legs, and when I was able to move after about 20 mins I began to violently vomit everywhere. I then kept shaking for another 35 mins before laying down. I then was breathing very heavy as it was hard to breathe due to the shaking. My legs still are very sore  and my memory is foggy.
Felt sickly and had an anxiety feeling with a facing heart.  Last a few hours.
Chills, fever and muscle aches for 24 hours, I took tylenol and motrin
PATIENT COMPLAINED OF HEADACHE, PAIN AND TINGLY SENSATION IN THE LEGS STARTING ON 4/16/2021
Vaccine dose #2 / R. Deltoid.  Received a call from patient today around 0930 reporting having sore throat, unusual coughing and congestion.  She also reported that she started feeling feverish with muscle pain 1 day after vaccine administration.  Denies other c/o, no respiratory problem.  Fever of 102.   Advised to call occupational health department for further instruction and to report to PCP.  Pt was tested for COVID, negative results.  Recovered in 7 days.  No follow up.  Took Dayquil, Mucinex, and Tylenol.
It was reported that after receiving vaccination the pt developed pain and swelling at the injection site within 48 hrs of administration.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 47-year-old male patient received BNT162b2 (BNT162B2), on 01Oct2021 at 13:30 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 46 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetes T2" (unspecified if ongoing); "asthma" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN, start date: 01Jan2010. Past drug history included: Erythromycin, reaction(s): "Known allergies: Erythromycin". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 08Aug2022 at 13:00, outcome "recovering" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (04Aug2022) Negative, notes: Tested negative 04Aug am; (05Aug2022) Negative, notes: Negative tests 05Aug, 06Aug and 08Aug am; (06Aug2022) Negative, notes: Negative tests 05Aug, 06Aug and 08Aug am; (06Aug2022) Negative, notes: Negative tests 05Aug, 06Aug and 08Aug am; (08Aug2022) Negative, notes: Negative tests 05Aug, 06Aug and 08Aug am; (08Aug2022) Positive, notes: Felt congested 08Aug afternoon, tested positive 08Aug at 1 pm. Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Systemic: Dizziness / Lightheadness-Medium, Additional Details: Extreme lightheadedness, patient said vision went black
A non-serious, spontaneous report of sore throat and cough has been received from a registered nurse concerning a 15-year-old female patient, subsequent to receiving H1N1, intranasal. The patient's medical history included an inhaler for exercise-induced asthma four years ago and hypothyroidism. Concomitant medications included levothyroxine sodium. The patient received H1N1, intranasal on 30-Oct-2009. On 31-Oct-2009, the patient experienced a sore throat and cough. The events of sore throat and cough resolved.
Complaint of nausea and dizziness. Reports having same reaction when blood drawn. Refused transport to hospital.
Pain and stiffness in neck that began about an hour after my vaccination and lasted about 6 weeks.  I sought medical attention after about 2 weeks and was prescribed a steroid for treatment at a Urgent Care facility. I also received 2 treatments at a chiropractor to help.
This case was reported by a nurse via sales rep and described the occurrence of influenza-like symptoms in a 70-year-old male patient who received SHINGRIX for prophylaxis. On 31st August 2018, the patient received the 1st dose of SHINGRIX. On 1st September 2018, 1 days after receiving SHINGRIX, the patient experienced sickness. On an unknown date, the patient experienced influenza-like symptoms, pain in arm, lethargy, sleepiness, jerkiness and dizziness. On an unknown date, the outcome of the influenza-like symptoms, pain in arm, lethargy, sleepiness, jerkiness, dizziness and sickness were unknown. It was unknown if the reporter considered the influenza-like symptoms, pain in arm, lethargy, sleepiness, jerkiness, dizziness and sickness to be related to SHINGRIX. Additional details reported as follows: This case was reported by the licensed practical nurse. The age at vaccination was not reported but the patient was around 70 years old. The patient received SHINGRIX on right arm. The reporter, stated to the representative that the patient experienced all the events less than 2 week after vaccination listed but did not have any time frames for onset. She did not give any specific answers as to which flu like symptoms the patient experienced. The patient was sick on Saturday, 1st September 2018 and Sunday, 2nd September 2018 after the injection. The patient slept for two days, but it was not mentioned which days. The patient was better now but his arm was extremely sore. This case has been linked with US2018166446 and US2018166443, reported by same reporter.
On day 3 patient started having tingling & muscle twitching on right side of face. On day 4 it progressed to drooping of the left side of face. Patient went to ER and was given steroids. On day 5 she developed left side weakness down entire side of body, arms and legs, which quickly progressed to entire body weakness and shaking.  She was admitted to hospital. All tests, including mri were negative.  On day 6 she had further weakness and numbness. A spinal tap was done and she was discharged from the hospital to await those results.
Severe Virtigo and loss of partial loss of hearing and vision. headaches and overall discomfort. Sluggish, unsteady
devel persistent nodule @ inj site; sterile abscess drained when enlarged & became fluctuant, needle aspirated7NOV94; surgical removal 25JAN95; stitch abscess 21MAY95;
On DPH @ time of vax for eczema; had high pitched constant crying p/vax for 24 hrs; had elevated temp w/1st set of DPT but didn't report it to MD or clinic; no temp w/this set lt leg swelled w/in 20 mins-no redness but warm to touch;
The day after receiving the shot I ran a low-grade fever. I hit a 100 degrees once. I was very tired and I slept a lot. On the 3rd day, I felt better, I was just tired. In 10-14 days, I started having chest pains. It progressively got worse. It went away and then came back. I went to the doctor on May 7th. I stopped taking Xeljanz just in case that was the issue. Since then, I have had only 3 doses of Celebrex. I also took Prilosec which did not do anything. The doctors did a CRT and an echocardiogram and a nuclear heart test which all came back normal.
pt recv vax 27AUG97 & same day taken to MD for school physical;MD reported to mom pt had a severe rxn to vax & should start ATB;swelling dec & no more redness;
no adverse effects; a first dose of GARDASIL 9 at age 12 (...) a second dose on 15-OCT-2019 at age 14; This spontaneous report as received from a physician assistant refers to a 14-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  In approximately 2017 (reported as "at age 12"), the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route of administration, lot # and expiration date were not reported) for prophylaxis. On 15-OCT-2019, the patient was in an office to be vaccinated with a second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (inappropriate schedule of product administration). There was no adverse event reported.
ill; flu like symptoms; arm swelled/  Immune cells migrating; This case was reported by a physician via sales rep and described the occurrence of unwell in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (received 1st dose on an unknown date, refer case US2021AMR206638).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, immediately after receiving Shingrix, the patient experienced unwell, influenza-like symptoms and swelling arm. On an unknown date, the outcome of the unwell, influenza-like symptoms and swelling arm were recovered/resolved.   It was unknown if the reporter considered the unwell, influenza-like symptoms and swelling arm to be related to Shingrix.  Additional details provided were as follows: The doctor self-reported this case. The age at vaccination was not reported but the patient could be approximately 59 years old at the time of reporting. The patient received 2nd dose of Shingrix and had flu like symptoms, fairly ill and arm swelled right after vaccination and it looked like Moderna arm and resolved within a week. One month later the patient received Pfizer Covid booster and his arm swelled 2 to 3 times worse than with Shingrix vaccine and lasted longer for 2 weeks. He thought that the Shingrix previously received one month before contributed to the adverse drug reaction (ADR) with the Covid booster. Immune cells migrating to skin were probably still there. He found that very interesting. He also had lymphadenopathy after Pfizer booster, but had no real issues with 1st and 2nd of Pfizer series. The reporter denied to follow-up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR206638:same reporter,same patient,1st dose
CHILLS, BODY ACHES, HEADACHE, STIFF NECK, LOW FEVER, UNCONTROLLED SHIVERING.  SUBSIDED AFTER 24 HOURS.
Pt came in on 10/5/18 at 730pm. Arm (R) swollen, hot to touch, red. Recom. pt. see MD.
Systemic: right lung pain for 4 days worsening with inhalation-Medium
Friday afternoon ... headache and right thigh muscle discomfort . Saturday ... headache and more  thigh muscle discomfort. By night, muscle ache was continual and continued throughout the night.  Very difficult to walk. Sunday ... called Telehealth around noon, They triaged me into Dr.'s office.  By Sunday afternoon, less discomfort, but still a headache. During this discomfort time, I would take 2 Tylenol (500 mg), which relieved it. Before I settled down for the night, I took 1 Tylenol and when I woke up at 3:00 a.m., the ache was not there (the Tylenol would have worn off by then). Monday a.m. ... could walk much better. The headache and the constant muscle ache are gone.  Nurse called; I am to keep watch, and if there are any changes for the worse, I will go into the Dr.'s office.
Immediately had swelling at site within five minutes of vaccination, nurse immediately applied ice to site, physician observe and recommended Benadryl and continue to apply ice PRN.
There was sudden reoccurrence of covid shot arm  itchiness and redness three months after shot. Arm was fine one minute and the next  was swollen and hard to the touch and incredibly itchy at the site of the injection. This persisted for half and hour at this intensity. With ice and Benadryl it calmed down.  The next day it is much smaller and improving.   This event also had occurred almost 6 days after each injection.
WHITE ZITS ON LEFT CHEEK; SORE ARM; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) dose was not reported, administered on 04-MAR-2021 to Right Arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 04-MAR-2021, the patient experienced sore arm. On 06-MAR-2021, the patient experienced white zits on left cheek. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm on 05-MAR-2021, and had not recovered from white zits on left cheek. This report was non-serious.
Improper storage of product in use; no adverse event; This spontaneous report was received from a nurse referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported.  On an unknown date, the patient started therapy with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 1 dose, lot #W025274, expiration date was not reported, but upon internal validation established as 10-AUG-2024, for prophylaxis (strength, and route of administration were not provided), while it had a temperature excursion (temperature 24.4 Fahrenheit (F) for time frame as 5 hours 51 minutes 0 seconds) (product storage error). There was no previous temperature excursion. No additional adverse event was reported (no adverse event). The patient was asymptomatic.
We gave patient 0.5ml instead of recommended 0.25ml. We found out the mistake the next day. Contacted dad and patient is doing fine, little tired but ok
approx 3 hrs p/vax given pt felt hot all over; trembling & shaking all over like chill; no jerking, eyes looked glassey; didn't cry or make a sound very lethargic; t103;
After the booster arm still hurts in shot area after 3 months like I just received it; This is a spontaneous report from a contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 55-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm, administration date 22Dec2021 at 16:00 (Lot number: FS8757) at the age of 55 years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot number: EW0171, Route of administration: Unspecified, Anatomical location: Left arm, Time of administration: 16:00), administration date: 06Apr2021, when the patient was 54 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE; Lot number: ER8737, Route of administration: Unspecified, Anatomical location: Left arm, Time of administration: 16:00), administration date: 27Apr2021, when the patient was 54 years old, for COVID-19 immunisation.  The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 22Dec2021 at 16:00, outcome "not recovered", described as "After the booster arm still hurts in shot area after 3 months like I just received it". Therapeutic measures were not taken as a result of the event vaccination site pain.  Additional Information: The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 26-JUL-2016 the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB 10 microgram/1 ml (lot # L014878, expiration date 17-JAN-2018, route unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 128 hours with highest recorded temperature of 49 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Positive for COVID 19; Positive for COVID 19; Breakthrough infection; This is a spontaneous report from a contactable other healthcare professional via sales representative. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date was not reported), via an unspecified route of administration, on an unspecified date, at dose number unknown,  single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced breakthrough infection and positive for COVID 19 on an unspecified date after vaccination. The patient underwent lab tests and procedures which included covid-19 test on an unspecified date which showed positive result. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: Based on the information currently available,The casual association between the reported Covid-19 and suspected vaccine BNT162B2 cannot be completely excluded.
Monday - extreme tiredness, some chills running nose Tuesday - deep chills temp 95 deg, pulse running  30-40 pts higher, blood pressure ok, visited  Dt , said it  could be reaction to  Janzen shot, said i need to hydrate better, drink lots of Gatorade Friday - Went to Hospital ER, Oxygen level low 90,  temp 103.4, high  bp - IV'd, Tested positive for Covid -19 gave me 4mg  methylprednisolone - 4 days
fever blister on her lip and tongue; fever 100F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 100F) and ORAL HERPES (fever blister on her lip and tongue) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced PYREXIA (fever 100F). On 24-Mar-2021, the patient experienced ORAL HERPES (fever blister on her lip and tongue). At the time of the report, PYREXIA (fever 100F) and ORAL HERPES (fever blister on her lip and tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant information  provided. No Treatment information  provided
pt recv vax @ noon;had emesis @ 3PM w/fever;fever cont;appeared afeb @ 4PM;started screaming & wouldn't move lt leg;t103.5 ax;
patient received dose two of Havrix 4 months after dose one instead of 6 months after dose one; This non-serious case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 1-year-old male patient who received HAV (Havrix) (batch number 95R7C, expiry date 05-MAY-2025) for prophylaxis.   Previously administered products included Havrix (On 26th June 2023, received one dose).   On 31-OCT-2023, the patient received Havrix. On 31-OCT-2023, an unknown time after receiving Havrix, the patient experienced drug dose administration interval too short (Verbatim: patient received dose two of Havrix 4 months after dose one instead of 6 months after dose one). The outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK Receipt Date: 02-NOV-2023 The nurse reported that the patient received dose two of Havrix 4 months after the dose one instead of 6 months after dose one. Lot number and expiration date for first dose was not provided.  No additional information were reported. The reporter consented to follow up. The patient received booster dose of Havrix vaccine, earlier than the recommended interval, which led to shortening of vaccinations schedule.
i received a phone call from mom who transfered out of our office to another state. while in this state, mom noticed that his eye was turning inward. mom stated that could not  get into a pediatric doctor so took him to see a doctor at clinic. per mom was told by that doctor that his eye turning inward was a result of his 4 yr. shots and that was common and told grow out of it or not. per mom that doctor called it cranial nerve palsy. mom then stated  went to eye doctor who told them that he needed glasses. per mom the doctor at clinic is suggesting that he get an MRI of the brain done.
December 31st had swollen lymph nodes, one went away quickly but still have one receding under left arm. 01/05 In the evening had sore throat and the start of laryngitis, when the morning came it was full blown laryngitis, scratchy and sore throat, sinus pressure and congestion. Called Dr. and set up an appt. 01/06 and it was done at 10am. Advised to get covid and strep throat tests. 01/07 My rapid test results was negative and Strep test was negative.  Called Doctor and stated head cold with laryngitis and was advised to take liquids and bed rest. 01/08 On the evening I was recovering and had a few symptoms left and by the 11th was fully recovered. Only thing left is the receding lymph node under left arm.
My right arm was very swollen, painful to touch; My right arm was very swollen, painful to touch; fever; numbness in top of neck near shot area for days; This is a spontaneous report from a contactable consumer (patient). This 64-year-old female patient received dose 1 of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE; lot number EN6202; expiration date: Jun2021) via an unspecified route of administration in Mar2021 at 08:30 as a single dose in the right arm for COVID-19 immunization. Medical history included high blood pressure. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to the vaccine. The patient's concomitant medications were not reported. The patient previously received sulfa from an unspecified date for an unspecified indication and experienced allergy.  In Mar2021 at 08:30 the patient experienced right arm was very swollen, painful to touch, fever, and numbness in top of neck near shot area for days. The patient did not receive any treatment for the events. The outcomes of right arm was very swollen, painful to touch, fever, and numbness in top of neck near shot area for days were recovered with lasting effects. It was also reported that since the vaccine, the patient had not been tested for COVID-19.
Information has been received from a pharmacist concerning a 50 year old male patient who on 15-MAY-2010 was vaccinated IM with a 0.5 ml dose of PNEUMOVAX 23 (Lot # 664535/0060Z, exp 03-FEB-2011) in right shoulder. On 16-MAY-2010 the patient had redness, pain and swelling at the injection site. Patient was treated with unspecified treatment. Patient sought unknown medical attention. At the time of report the patient's status was recovering. The patient was hospitalized at the hospital for unrelated issue and PNEUMOVAX 23 was given as routine vaccination and did not prolong the hospitalization. This is one of several reports from the same source. No further information is available.